General Information
As of 02/09/2010
|
| NAV |
$13.12 |
| NAV Daily Change |
$0.11 |
| % Yield |
0 |
| % SEC Yield |
N/A |
| % YTD Return (as of 12/31/2009) |
11.04 |
| Objective* |
Equity - Sector Health |
| Peer* |
HL |
* Key
Portfolio Statistics
|
| % Unrealized Gain YTD |
15.96 |
| Net Assets (Mil $) 09/30/2009 |
34.03 |
| % Turnover 09/30/2009 |
162.00 |
Fees
|
| % Max Sales Load |
5.75 |
| % Min Sales Load |
.00 |
| % Max Deferred Load |
.00 |
Expenses
|
| % Max 12b-1 Fee |
.25 |
| % Max Management Fee |
1.00 |
| % Redemption Fee |
.00 |
| % Expense Ratio |
1.55 |
Allocation
|
| Large Growth |
54.24 |
| Large Value |
.00 |
| Small Growth |
21.32 |
| Small Value |
.00 |
| Foreign Stock |
.00 |
| Emerging Market |
.00 |
| Precious Metals |
.00 |
| Intermediate Bond |
.00 |
| Foreign Bond |
.00 |
| High Yield Bond |
.00 |
Portfolio Information |
| Composition |
| As of 09/30/2009 |
% of Net Assets |
| Stock |
99.86 |
| Cash |
.00 |
| Bonds |
.00 |
| Preferred |
.00 |
| Convertibles |
.00 |
| Foreign Stock |
2.56 |
| Foreign Bonds |
.00 |
| Hedge |
.00 |
| Other |
.14 |
Sector / Country Weightings
|
Sector / Country Weightings
|
| As of 09/30/2009 |
% of Portfolio |
| Health |
65.27 |
| Finance |
30.99 |
| Services |
13.19 |
| Technology |
4.08 |
| Retail Trade |
3.13 |
| Industrial Cyclical |
.99 |
| Other |
-17.65 |
| N/A |
N/A |
| N/A |
N/A |
Portfolio Holdings |
Top Equity Holdings
(As of 09/30/2009) |
% of Portfolio |
Value (Mil$) |
|
| AIM LIQUID ASSETS PTF |
24.09 |
9.04 |
| GILEAD SCIENCES |
7.79 |
2.92 |
| WYETH LTD |
7.64 |
2.87 |
| PFIZER INC |
7.40 |
2.78 |
| AMGEN |
6.18 |
2.32 |
| BECKMAN COULTER INC |
4.00 |
1.50 |
| UNITEDHEALTH GROUP |
3.67 |
1.38 |
| ABBOTT LABORATORIES |
3.57 |
1.34 |
| JOHNSON & JOHNSON |
3.13 |
1.17 |
| N/A |
N/A |
N/A |
|
|
This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Funds over the next 6 months.
| Zacks Rank |
Definition |
| #1 |
Strong Buy |
| #2 |
Buy |
| #3 |
Hold |
| #4 |
Sell |
| #5 |
Strong Sell |
| S&P |
500 |
Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Zacks Premium Research
|
Zacks Mutual Fund Rank
|
| |
Find similar funds that have a Mutual Fund Rank.
Find Similar Funds Now 
|
Fund Description
|
The fund was incepted February 2001 and is managed by Turner Investment Partners. The objective of this fund is to seek long-term capital appreciation. The fund invests primarily in equity securities issued by healthcare and biotechnology companies that are traded in the United States. The advisor invests in growth companies with superior earnings prospects, reasonable valuations and favorable trading-volume and price patterns. While the fund typically invests in the common stocks of medium to large capitalization companies, it may invest in companies of any size or any industry in order to achieve its goal. The fund offers dividends and capital gains, if any, at least annually.
|
Stock Holding Statistics
% of Net Assets
|
| As Of |
09/30/2009 |
| Total Issues |
49 |
| Avg. P/E |
25.47 |
| Avg. P/Book |
5.09 |
| Avg. EPS Growth |
13.51 |
| Avg. Market Value (Mil $) |
38,214 |
Risk
|
|
3 Year |
5 Year |
10 Year |
| Beta |
0.67 |
0.67 |
0.00 |
| Alpha |
1.30 |
0.21 |
0.00 |
| R Squared |
0.62 |
0.59 |
0.00 |
| Std. Dev. |
16.74 |
13.95 |
0.00 |
| Sharpe |
-0.29 |
-0.13 |
0.00 |
Shareholder Information
|
| Manager |
Team Managed |
| Since |
N/A |
| Manager Rating * SEE EXPLANTION |
N/A |
| Inception Date |
02/28/2001 |
| Shareholders |
0 |
| Dividends Paid |
A |
| Minimum Initial Investment |
$2,500 |
| Minimum Subsequent Investment |
$50 |
| IRA Minimum |
$1000 |
| IRA Available |
Y |
Check Writing |
N |
Phone Invest |
Y |
| Phone Exchange |
Y |
Phone Redeem |
Y |
Auto Invest |
Y |
| Wire Redeem |
N |
Wire Fee |
N |
Wire Transfer |
N |
Contact Information
|
| Family |
Constellation |
| Address |
P.O. Box 219805
Kansas City, MO 64121 |
| Phone |
866 242-5742 |
|
Sponsored Links 
